Related Experiment Video
Updated: Feb 3, 2026

Assays for the Identification of Novel Antivirals against Bluetongue Virus
Published on: October 11, 2013
Hepatitis C virus, directly acting antivirals and Guillain-Barré syndrome
Manish Balwani1, Charulata Bawankule2, Vishal Ramteke2
1Department of Nephrology, Jawaharlal Nehru Medical College, Wardha, Maharashtra, India.
Abstract:
Guillain-Barré syndrome (GBS) has been associated with both infective and noninfective etiologies. It is usually preceded by acute gastrointestinal or respiratory infections. We report an unusual case of GBS in a hepatitis C virus-positive hemodialysis (HD)-dependent patient who was being treated with sofosbuvir and daclatasvir along with antitubercular drugs for pulmonary tuberculosis. One should keep GBS in the differential diagnosis in HD patients whenever patient presents with lower limb weakness. Early diagnosis will help in timely initiation of treatment which is crucial to treat GBS.
More Related Videos
Related Concept Videos
Forces Acting on Chromosomes
Microtubules and motor proteins exert two types of forces on...
What are Viruses?
The Antiviral System of Bacteria and Archaea: CRISPR
Effect of Hepatic Disease on Pharmacokinetics: Dose Adjustments Due to Hepatic Impairment
Hepatic Portal System
At its core, the hepatic portal vein is the result of a confluence of the superior and inferior mesenteric veins along with the splenic vein. Each of these veins has a unique role. The superior mesenteric vein is...
Direct-Acting Cholinergic Agonists: Pharmacokinetics

